Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.42 |
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | CA9 | Q16790 | 4/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | AGXT | P21549 | 2/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | PREP | P48147 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LPO | P22079 | 1/20 | 0.34 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.34 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29975825 | 1.00 | CA12 (0.42) | CA12CA1CA9IDO1AGXT | |
| SCHEMBL19745618 | 0.87 | CA12 (0.40) | CA12CA1CA9IDO1AGXT | |
| SCHEMBL14382682 | 0.86 | CA12 (0.42) | CA12CA1CA9IDO1AGXT | |
| SCHEMBL559965 | 0.85 | KDR (0.41) | CA12CA1CA9IDO1AGXT | |
| SCHEMBL3866939 | 0.85 | MAOB (0.43) | CA12CA1CA9IDO1AGXT | |
| SCHEMBL558917 | 0.85 | CA12 (0.41) | CA12CA1CA9IDO1AGXT | |
| SCHEMBL4327915 | 0.85 | CA12 (0.44) | CA12CA1CA9IDO1AGXT | |
| SCHEMBL29851528 | 0.85 | KDR (0.41) | CA12CA1CA9IDO1AGXT | |
| SCHEMBL2217582 | 0.84 | TAAR1 (0.41) | IDO1AGXTTAAR1CNR1CNR2 | |
| SCHEMBL7706827 | 0.83 | CA1 (0.50) | CA12CA1CA9HSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626548-A1 | NON PEPTIDERGIC AGONISTS OF OXYTOCIN RECEPTOR | Université de Strasbourg (FR) | 2025-10-08 | — | — | EP | disclosed |
| US-12213973-B2 | Bacterial nitric oxide synthase inhibitors | NORTHWESTERN UNIVERSITY (US) | 2025-02-04 | — | — | US | disclosed |
| WO-2024115667-A1 | NON PEPTIDERGIC AGONISTS OF OXYTOCIN RECEPTOR | UNIVERSITE DE STRASBOURG (FR) | 2024-06-06 | — | — | WO | disclosed |
| US-20240018131-A1 | MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF | FORESEE PHARMACEUTICALS USA, INC. | 2024-01-18 | — | — | US | disclosed |
| US-11739080-B2 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | FORESEE PHARMACEUTICALS USA, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-11725000-B2 | Apoptosis inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2023-08-15 | — | — | US | disclosed |
| US-20230210840-A1 | BACTERIAL NITRIC OXIDE SYNTHASE INHIBITORS | NORTHWESTERN UNIVERSITY | 2023-07-06 | — | — | US | disclosed |
| US-20230210840-A1 | BACTERIAL NITRIC OXIDE SYNTHASE INHIBITORS | NORTHWESTERN UNIVERSITY | 2023-07-06 | — | — | US | disclosed |
| US-20210309647-A1 | Apoptosis Inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2021-10-07 | — | — | US | disclosed |
| US-11034680-B2 | Apoptosis inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2021-06-15 | — | — | US | disclosed |
| EP-0462830-B1 | Cyclic ether derivatives | ZENECA LTD (GB) | 1995-10-18 | — | — | EP | disclosed |
| US-5407945-A | Pyran derivatives and their use as inhibitors of 5-lipoxygenase | IMPERIAL CHEMICAL INDUSTRIES, INC. (GB) | 1995-04-18 | — | — | US | disclosed |
| US-5262540-A | FOR INHIBITION OF BLOOD PLATELET AGGREGATION IN MAMMALS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-11-16 | — | — | US | disclosed |
| US-5254581-A | Used in the treatment of various inflammatory and allergic diseases | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-10-19 | — | — | US | disclosed |
| US-5077305-A | Anticoagulants | BRISTOL-MYERS SQUIBB CO. (US) | 1991-12-31 | — | — | US | disclosed |
| EP-0462830-A2 | Cyclic ether derivatives | ZENECA LIMITED (GB) | 1991-12-27 | — | — | EP | disclosed |
| EP-0442448-A2 | Heterocyclic carboxylic acids and esters | Bristol-Myers Squibb Company (US) | 1991-08-21 | — | — | EP | disclosed |
| EP-0434034-A1 | Oxazole derivatives | Bristol-Myers Squibb Company (US) | 1991-06-26 | — | — | EP | disclosed |
| US-5011851-A | Imidazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith | BRISTOL-MYERS SQUIBB CO. (US) | 1991-04-30 | — | — | US | disclosed |
| US-4956379-A | Anticoagulants | BRISTOL-MYERS SQUIBB COMPANY (US) | 1990-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11725000-B2 | Apoptosis inhibitors | BAX, SDHA, SDHB | CA12 3096/4885CA1 1080/4885CA9 2210/4885 |
| US-12213973-B2 | Bacterial nitric oxide synthase inhibitors | NOS1, NOS2, NOS3 | CA12 4531/4885CA1 3039/4885CA9 2513/4885 |
| US-20240018131-A1 | MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF | MMP12, MMP1, MMP11 | CA12 165/4885CA1 1241/4885CA9 424/4885 |
| US-11739080-B2 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | MMP12, MMP1, MMP11 | CA12 165/4885CA1 1241/4885CA9 424/4885 |
| US-20230210840-A1 | BACTERIAL NITRIC OXIDE SYNTHASE INHIBITORS | NOS1, NOS2, NOS3 | CA12 4531/4885CA1 3039/4885CA9 2513/4885 |
| US-11034680-B2 | Apoptosis inhibitors | BAX, SDHA, SDHB | CA12 3096/4885CA1 1080/4885CA9 2210/4885 |
| US-20210309647-A1 | Apoptosis Inhibitors | BAX, SDHA, SDHB | CA12 3096/4885CA1 1080/4885CA9 2210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.